About Pricing FAQs Providers Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Study of CM310 in Patients With Allergic Rhinitis | Clinical Trials | Clareo Health

Back to clinical trial search

COMPLETEDPhase 2NCT05908721

Study of CM310 in Patients With Allergic Rhinitis

This study is a multicenter, single arm, open-label phase II clinical study mainly evaluating the safety of CM310 in patients with allergic rhinitis.

Lead sponsor: Keymed Biosciences Co.Ltd•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

Keymed Biosciences Co.Ltd

Allergic rhinitis (AR) is a non infectious chronic inflammatory disease of the nasal mucosa that is mainly mediated by immunoglobulin E (IgE) in atopic individuals exposed to allergens.

Age

18 - 65 years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•Male or female aged 18-65.
•Understand the study and sign the Informed Consent Form voluntarily.
•Take effective contraception measures throughout the study period.

Exclusion Criteria

•Used other investigational drugs.
•Allergies to drugs with IL-4Rα monoclonal antibody or drug components of CM310.
•Plan to participate in other studies during this clinical trial.
•With malignant or benign tumors of the nasal cavity.
•Other reasons the researcher believes that the subject is not suitable to participate in this study.

Related studies

Dietary Intervention on Atopy

NCT06547372 · Atopic Dermatitis, Atopic, and more

Evaluation of a Digital Tool to Improve Aeroallergen Immunotherapy Adherence. NavigAITme Project

NCT07419230 · Allergic Rhinitis

Effect of AI(Artificial Intelligence)-Based Storytelling Video on Anxiety and Fear During Skin Prick Test in Children

NCT07453615 · Anxiety, Fear Anxiety, and more

A Biorepository of Multiple Allergic Diseases (MADREP) With Longitudinal Follow-Up

NCT06732414 · Allergy, Sinus Disorders, Atopic Diseases, Asthma, Allergic Rhinitis, Atopic Dermatitis, EoE, Drug a

Safety and Performance Assessment of the Decongestant Seawater Spray Pocket Valve Enriched With Essential Oils in Patients With Acute Rhinitis Associated With Nasal Obstruction: "DEVALPO"

NCT05494346 · Acute Rhinitis, Nasal Obstruction, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: November 8, 2024Terms

Trial snapshot

StatusCOMPLETED

PhasePHASE2

Enrollment100

Start dateAug 2023

Last updatedNov 8, 2024

Condition

Allergic Rhinitis

Locations shown

Beijing Tong-Ren hospital

Beijing

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: November 8, 2024Data synced to Clareo: July 13, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions